Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group.
Cseh A, Niemeyer CM, Yoshimi A, Dworzak M, Hasle H, van den Heuvel-Eibrink MM, Locatelli F, Masetti R, Schmugge M, Groß-Wieltsch U, Candás A, Kulozik AE, Olcay L, Suttorp M, Furlan I, Strahm B, Flotho C. Cseh A, et al. Among authors: olcay l. Blood. 2015 Apr 2;125(14):2311-3. doi: 10.1182/blood-2015-01-619734. Blood. 2015. PMID: 25838281 Free article. No abstract available.
Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study group.
Cseh AM, Niemeyer CM, Yoshimi A, Catala A, Frühwald MC, Hasle H, van den Heuvel-Eibrink MM, Lauten M, De Moerloose B, Smith OP, Bernig T, Gruhn B, Kulozik AE, Metzler M, Olcay L, Suttorp M, Furlan I, Strahm B, Flotho C. Cseh AM, et al. Among authors: olcay l. Br J Haematol. 2016 Mar;172(6):930-6. doi: 10.1111/bjh.13915. Epub 2016 Jan 13. Br J Haematol. 2016. PMID: 26766110 Free article.
Benefit of high-dose methylprednisolone in comparison with conventional-dose prednisolone during remission induction therapy in childhood acute lymphoblastic leukemia for long-term follow-up.
Yetgin S, Tuncer MA, Cetin M, Gümrük F, Yenicesu I, Tunç B, Oner AF, Toksoy H, Koç A, Aslan D, Ozyürek E, Olcay L, Atahan L, Tunçbilek E, Gürgey A. Yetgin S, et al. Among authors: olcay l. Leukemia. 2003 Feb;17(2):328-33. doi: 10.1038/sj.leu.2402673. Leukemia. 2003. PMID: 12592331 Clinical Trial.
A child with myelodysplastic syndrome with hypocellular fibrosis.
Akyay A, Olcay L, Kuzu I, Bozdoğan N, Ünal-İnce E, İleri T, Tükün A, Yürür-Kutlay N. Akyay A, et al. Among authors: olcay l. J Pediatr Hematol Oncol. 2010 Nov;32(8):617-20. doi: 10.1097/MPH.0b013e3181e6262c. J Pediatr Hematol Oncol. 2010. PMID: 20818271
Congenital dysgranulopoietic neutropenia.
Olcay L, Yetgin S, Erdemli E, Germeshausen M, Aktaş D, Büyükaşik Y, Okur H. Olcay L, et al. Pediatr Blood Cancer. 2008 Jan;50(1):115-9. doi: 10.1002/pbc.20877. Pediatr Blood Cancer. 2008. PMID: 16652351
79 results